AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 90 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $12,813,000 | -4.9% | 611,893 | -5.5% | 4.89% | +10.7% |
| Q2 2019 | $13,476,000 | -6.8% | 647,254 | 0.0% | 4.42% | +17.3% |
| Q1 2019 | $14,466,000 | -14.8% | 647,254 | -8.8% | 3.77% | -32.5% |
| Q4 2018 | $16,979,000 | -22.3% | 709,822 | -11.4% | 5.58% | +15.6% |
| Q3 2018 | $21,858,000 | -4.5% | 801,240 | -5.9% | 4.82% | -2.2% |
| Q2 2018 | $22,889,000 | -23.1% | 851,213 | -9.0% | 4.93% | -24.0% |
| Q1 2018 | $29,762,000 | +2.9% | 935,020 | +22.3% | 6.49% | -20.1% |
| Q4 2017 | $28,926,000 | +27.9% | 764,824 | -16.1% | 8.12% | +30.4% |
| Q3 2017 | $22,609,000 | +20.6% | 912,001 | 0.0% | 6.23% | +1.7% |
| Q2 2017 | $18,751,000 | -5.4% | 912,001 | 0.0% | 6.12% | -19.5% |
| Q1 2017 | $19,818,000 | +7.2% | 912,001 | +0.9% | 7.61% | -5.3% |
| Q4 2016 | $18,485,000 | +31.8% | 903,890 | -3.3% | 8.03% | +22.5% |
| Q3 2016 | $14,025,000 | +451.5% | 935,020 | +297.8% | 6.56% | +275.6% |
| Q2 2016 | $2,543,000 | -47.2% | 235,020 | -33.8% | 1.74% | -53.2% |
| Q1 2016 | $4,814,000 | -26.5% | 355,020 | 0.0% | 3.72% | -35.9% |
| Q4 2015 | $6,550,000 | – | 355,020 | – | 5.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|